Results 71 to 80 of about 27,286 (132)

Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis. [PDF]

open access: yesEur Heart J, 2021
Wang Q   +13 more
europepmc   +1 more source

ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients

open access: yesLipids in Health and Disease
Type 2 diabetes mellitus (T2DM) is a globally prevalent metabolic disorder, and cardiovascular disease (CVD) is a significant cause of mortality and morbidity in diabetic individuals. In addition to hyperglycemia, lipid abnormalities associated with T2DM
Jingfei Chen   +6 more
doaj   +1 more source

Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence

open access: yesPharmacological Research
Han-Yong Hou   +4 more
doaj   +1 more source

Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome. [PDF]

open access: yesCirc Rep
Tanaka H   +9 more
europepmc   +1 more source

Circulating Angiopoietin-Like Protein 3 Level and Plaque Calcification: An Optical Coherence Tomography Imaging Analysis. [PDF]

open access: yesCJC Open
Kataoka Y   +14 more
europepmc   +1 more source

Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial. [PDF]

open access: yesNat Med
Gaudet D   +12 more
europepmc   +1 more source

Unveiling the PGAM5-ANGPTL3 Axis

open access: yesJACC: Basic to Translational Science
Eva Hurt-Camejo, PhD
doaj   +1 more source

Home - About - Disclaimer - Privacy